The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research aimed at bringing treatments and a cure to patients, is pleased to announce the appointment of health insurance industry veteran Wendy Arnone to its Board of Directors.

Wendy is a highly experienced executive with a clinical background, and has held leadership roles within insurance providers including UnitedHealthcare, Excellus BlueCross BlueShield, and HealthNow New York Inc. Wendy most recently served as West Region CEO for UnitedHealthcare’s Individual and Employer business, a $10 billion region encompassing thirteen states with over three million members. She brings an incredible wealth of healthcare industry expertise to the CMTA Board of Directors, along with significant leadership experience and financial acumen.

“It is a true honor to join the esteemed Board of Directors at the CMTA, an organization that embodies a never-ending dedication to accelerating research and providing support for those affected by CMT,” said Wendy. “My journey with CMT spans over three decades, diagnosed at a time when research and resources were scarce. Through the remarkable work of the CMTA, I have witnessed firsthand the transformative impact of their initiatives on individuals living with this condition, including myself. I am deeply inspired by the opportunity to contribute my expertise from the healthcare industry towards driving progress and fostering hope for a brighter future. Together, we will continue to champion innovation, awareness, and ultimately, a world free of CMT.”

“We are excited to welcome Wendy Arnone to the CMTA Board of Directors,” said Gilles Bouchard, CMTA Chairman of the Board. “The depth and breadth of her executive experience in healthcare, combined with her passion for helping patients, will be invaluable as we continue our drive to achieve our vision of a world without CMT.”